President Donald Trump’s boast Thursday to have lowered weight-loss drug costs was made potential by former President Joe Biden’s signature piece of laws, which handed with zero Republican votes.
Biden’s Inflation Discount Act, which handed in 2022, requires pharmaceutical corporations to barter drug costs with Medicare.
However that didn’t cease Trump from claiming credit score.
“This will slash the cost of Wegovy from $1,350 a month to ultimately $250 a month,” Trump mentioned. “$1,350 to $250 — did I do a good job?”
“They don’t write about it, you know they like to not write these things,” he added, throwing the press below the bus. “You think Biden could’ve done this? I don’t think so.”
Trump appeared oblivious to the truth that Biden actually did it.
Per Reuters, below the phrases of the deal, drug producers Novo Nordisk and Eli Lilly have agreed to promote their smallest, starter doses of their GLP-1-based weight-loss medication for $149 a month for Medicare and Medicaid enrollees.
In the course of the White Home announcement of the deal, a person standing behind the president within the Oval Workplace appeared to break down. Press secretary Karoline Leavitt instructed reporters that “a representative with one of the companies fainted” however is now OK. She didn’t determine the person.
Sen. Ron Wyden (D-Ore.) stole the president’s thunder forward of Thursday’s announcement with considered one of his personal.
“The announcement of a lower price for Ozempic and other anti-obesity drugs is made possible by Medicare negotiation, which Democrats passed with no Republican support,” Wyden famous in an announcement.
“Medicare negotiated lower prices weeks ago, and rather than share those prices, Trump is too busy hosting CEOs from Big Pharma at the White House with fake announcements that juice their stock prices,” he continued.
“It’s also important to keep in mind that one of Robert Kennedy’s first actions in office was to revoke a plan to allow Medicare to cover these drugs.”
